Point72 Asset Management, L.P. - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,655,330
-76.1%
2,557,000
-70.1%
0.01%
-76.2%
Q2 2023$6,938,296
-17.1%
8,557,000
+0.7%
0.02%
-19.2%
Q1 2023$8,364,698
+105.1%
8,500,000
+112.5%
0.03%
+62.5%
Q3 2022$4,079,000
+1.3%
4,000,0000.0%0.02%
-5.9%
Q2 2022$4,027,000
-5.5%
4,000,0000.0%0.02%0.0%
Q1 2022$4,260,0004,000,0000.02%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 45,000,000$474,089,0009.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,000,000$4,280,0000.96%
DeepCurrents Investment Group LLC 22,150,000$23,650,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 19,000,000$19,967,0000.46%
Context Capital Management, LLC 5,750$6,138,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 34,000,000$36,271,0000.35%
Polar Asset Management Partners Inc. 15,000,000$15,993,0000.17%
LINDEN ADVISORS LP 20,000,000$21,281,0000.13%
Wellesley Asset Management 1,599$1,599,0000.11%
Verition Fund Management LLC 6,213,000$6,614,0000.08%
View complete list of TRAVERE THERAPEUTICS INC shareholders